Access1 Access2 Access3 Medication & Drugs Respiratory June 2, 2022 Biologics For Severe Asthma: A Review of Dupilumab (Dupixent)
Access1 Access2 Access3 Cancer Medication & Drugs May 19, 2022 HSA Approves First-In-Class Sacituzumab Govitecan (Trodelvy) for Metastatic Triple Negative Breast Cancer (mTNBC)
Access1 Access2 Access3 Medication & Drugs Skin May 5, 2022 HSA Approves New JAK inhibitor Abrocitinib (Cibinqo) For The Treatment of Atopic Dermatitis
Access1 Access2 Access3 Medication & Drugs April 14, 2022 Contrave: A New Treatment Option For Weight Management
Access1 Access2 Access3 Medication & Drugs Muscles & Joints Skin April 7, 2022 The Newest JAK inhibitor for Psoriatic Arthritis: Upadacitinib (Rinvoq)
Access1 Access2 Access3 Medication & Drugs Mental Health March 31, 2022 Esketamine (Spravato) for Treatment Resistant Depression
Access1 Access2 Medication & Drugs March 24, 2022 Singapore’s HSA New Drugs and Indications Approval – Feb 2022
Access1 Access2 Access3 Medication & Drugs Muscles & Joints March 17, 2022 Upadacitinib (Rinvoq): Once-Daily Oral Treatment for Rheumatoid Arthritis (RA)
Access1 Access2 Access3 Medication & Drugs Nervous System March 11, 2022 Fremanezumab (Ajovy): Migraines – A True Pain to Treat